Salinomycin-loaded PEGylated poly (lactic-co-glycolic acid) NPs (SAL-NP) conjugated with CD133 aptamers (Ap-SAL-NP) reduced the proportion of CD133+ osteosarcoma cells [103]. The gene discussed is PROM1; the disease is osteosarcoma.